Nabla is integrating its AI medical scribe with Navina's AI-enabled copilot to provide doctors with an AI layer that supports clinical workflows.
The aim is to deliver real-time support through the full clinical encounter, according to the companies.
The integration combines Navina’s clinician copilot with Nabla’s in-visit ambient documentation, reconciling historical patient records with live patient dialogue to help improve patient outcomes and financial performance.
Navina, founded in 2018, developed an AI copilot that assists clinicians at the point of care by presenting actionable insights on a patient’s health history. Navina’s software facilitates physicians’ participation in value-based care models, and it ingests data from multiple clinical sources and brings it into context to provide in-visit insights, including missed conditions, open care gaps and coding opportunities in real time.
Nabla, also a seven-year-old company, automates clinical note-taking, but the company's tech goes far beyond ambient documentation. Nabla has been making headway with clients by helping them automate an increasing number of workflows and use AI to ease repetitive tasks, executives told Fierce Healthcare last month.
Nabla and Navina's joint solution will enhance care quality and improve documentation for reimbursement and help reduce clinician burnout, the companies said.
Navina’s proprietary AI engine ingests Nabla’s ambient conversation data and aligns it with historical records streaming from multiple sources and modalities, including labs, imaging, unstructured notes and audio.
The tech integration also eases the workload for clinicians, who will no longer have to toggle between notes, the electronic health record and third-party tools, executives said. The aim, Navina and Nabla say, is to create an AI layer that works alongside clinicians to ensure the right care is delivered, the right codes are captured and nothing clinically important falls through the cracks, executives said.
"Our partnership with Navina reinforces our commitment to embedding deeper and broader AI capabilities across clinical workflows,” said Alex Lebrun, co-founder and CEO of Nabla, in a statement. “We’re excited about the potential this collaboration unlocks for clinicians, equipping them with timely insights to elevate patient care while maximizing documentation accuracy and reimbursement."
Physicians are navigating an increasingly complex healthcare system with growing administrative burdens and tighter compliance and documentation requirements while regulators push providers into downside-risk arrangements.
The Centers for Medicare and Medicaid Services (CMS) and the Center for Medicare and Medicaid Innovation (CMMI) are increasingly emphasizing downside risk arrangements in their payment models, indicating that these will likely become mandatory in the future. In this environment, accurate, complete, and clinically grounded documentation will be critically important.
As value-based care demands more from physicians, Nabla and Navina say their partnership helps providers close care gaps and improve audit-ready documentation and reimbursement.
Nabla’s ambient visit data combined with Navina’s AI-driven condition suspecting and care gap engines can help healthcare organizations, including health systems, ACOs, MSOs, and medical groups, to drive measurable improvements in quality metrics, risk adjustment, clinician satisfaction and patient outcomes, executives state.
Both companies recently banked series C funding rounds. In March, Navina raised $55 million backed by Growth Equity at Goldman Sachs Alternatives, along with investors Vertex Ventures Israel, Grove Ventures and ALIVE.